Elite Pharmaceuticals Inc (ELTP): Vyvanse patent expires soon

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Sunday, 01/29/2023 3:42:47 PM

Sunday, January 29, 2023 3:42:47 PM

Vyvanse patent expires soon

Keep Last Read

Next 10 Prev Next

Form 8-K - Current report • Edgar (US Regulatory) • 08/27/2024 08:30:16 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2024 09:16:11 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:05:53 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 08:07:15 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2024 08:30:31 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 09:55:26 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 07:21:28 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2023 09:20:29 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 09:20:20 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/28/2023 12:05:38 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:58:46 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:50:54 PM
Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration with ZenaDrone • InvestorsHub NewsWire • 11/16/2023 12:32:07 PM

InvestorsHub NewsWire

Only $200 per official company press release!